Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for future investment returns [5]. Core Views - The company plans to repurchase shares for employee stock ownership plans, signaling confidence in long-term development [1][2]. - The trend of mattress manufacturing returning to the U.S. continues due to anti-dumping tariffs and trade policies, impacting imports from various countries including China [2][3]. - The company's operational efficiency in U.S. production bases is improving, with profitability achieved in 2024, and the North American market is expected to contribute significantly to profits [3]. - Domestic consumption stimulus policies are being enhanced, and the company is diversifying its sales channels, which is likely to improve its competitiveness and brand influence in the domestic market [3]. - The report forecasts a profit turnaround, with projected net profits of 307 million, 464 million, and 573 million yuan for 2025, 2026, and 2027 respectively, alongside corresponding EPS of 0.54, 0.81, and 1.00 yuan [3][10]. Summary by Sections Share Repurchase - The company intends to repurchase shares worth 0.85 to 1.7 billion yuan at a maximum price of 10.90 yuan per share, which will account for 1.37% to 2.73% of the total share capital [1][2]. Market Trends - The U.S. has implemented multiple rounds of anti-dumping tariffs on mattresses, leading to a significant decrease in imports, with a projected decline of 12.7% and 9.6% in 2023 and 2024 respectively [2]. - The continuation of high anti-dumping tariffs on Chinese mattresses indicates a sustained trend of "de-China" and manufacturing returning to the U.S. [2]. Financial Projections - The report projects revenue growth from 7.976 billion yuan in 2023 to 12.725 billion yuan in 2027, with a compound annual growth rate of approximately 14.33% [10]. - The company is expected to achieve a gross profit margin of around 38.4% by 2027, indicating stable profitability [12]. Profitability and Valuation - The report anticipates a significant increase in net profit margins, with a forecasted return on equity (ROE) of 11.87% by 2027 [12]. - The price-to-earnings (P/E) ratio is projected to decrease from 42 in 2023 to 8 by 2027, suggesting an attractive valuation as earnings improve [13].

Investment Rating - The report maintains a "Buy" rating for the company, indicating a favorable outlook for investment returns over the next 6-12 months [5]. Core Views - The company plans to repurchase shares for employee stock ownership plans, signaling confidence in long-term development [1][2]. - The U.S. mattress manufacturing is experiencing a trend of returning production to domestic markets due to anti-dumping tariffs and trade policies, which is expected to continue [2][3]. - The company is expected to benefit from improved operational efficiency in its U.S. production bases and the ongoing development of its online business and retail channels, leading to enhanced profit contributions from the North American market [3]. - The report forecasts a profit turnaround, with projected net profits for 2025-2027 being 307 million, 464 million, and 573 million yuan respectively, alongside corresponding EPS of 0.54, 0.81, and 1.00 yuan [3][10]. Summary by Sections Share Repurchase - The company intends to repurchase shares worth between 0.85 to 1.7 billion yuan at a maximum price of 10.90 yuan per share, which will account for 1.37% to 2.73% of the total share capital [1][2]. Market Trends - The U.S. has implemented multiple rounds of anti-dumping tariffs on mattresses from various countries, including China, which has led to a significant decrease in mattress imports, with a year-on-year decline of 12.7% and 9.6% expected for 2023 and 2024 respectively [2]. Financial Projections - The report projects revenue growth from 7.976 billion yuan in 2023 to 12.725 billion yuan in 2027, with a compound annual growth rate of approximately 14.33% [10]. - The company’s net profit is expected to recover from a loss of 151 million yuan in 2024 to a profit of 307 million yuan in 2025, reflecting a significant turnaround [10]. Profitability Metrics - The report anticipates an improvement in profitability, with the gross margin expected to stabilize around 38.4% by 2027, and a projected return on equity (ROE) of 11.87% in the same year [12].

安徽富乐德科技发展股份有限公司监事会 关于公司2024年限制性股票激励计划剩余预留授予激励对象 名单（截至授予日）的核查意见 （三）最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行政处 罚或者采取市场禁入措施； （四）具有《公司法》规定的不得担任公司董事、高级管理人员情形的； （五）法律法规规定不得参与上市公司股权激励的； （六）中国证监会认定的其他情形。 安徽富乐德科技发展股份有限公司（以下简称"公司"）监事会依据《中华 人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》 《上市公司股权激励管理办法》（以下简称"《管理办法》"）、《深圳证券交 易所创业板股票上市规则》（以下简称"《上市规则》"）、《深圳证券交易所 创业板上市公司自律监管指南第1号——业务办理》和《安徽富乐德科技发展股份 有限公司章程》（以下简称"《公司章程》"）等有关规定，对公司2024年限制 性股票激励计划（以下简称"本次激励计划"）剩余预留授予的激励对象名单（截 至授予日）进行了核查，发表核查意见如下： 一、公司本次激励计划剩余预留授予的激励对象与公司 2023 年年度股东大会 批准的《安徽富乐德科技发 ...

证券代码：688366 证券简称：昊海生科 上海昊海生物科技股份有限公司 及 2025 年第一次 H 股类别股东大会 会议资料 二〇二五年六月十日·上海 目 录 关于取消监事会并修订《公司章程》、 为了维护全体股东的合法权益、确保股东大会的正常秩序和议事效率，保证 股东大会的顺利进行，上海昊海生物科技股份有限公司（以下简称"公司"）根 据《中华人民共和国公司法》 （以下简称"《公司法》"）、 《中华人民共和国证券法》 （以下简称"《证券法》"）以及《上海昊海生物科技股份有限公司章程》 （以下简 称"《公司章程》"）、 《上海昊海生物科技股份有限公司股东大会议事规则》 《股东大会议事规则》及《董事会议事规则》 上海昊海生物科技股份有限公司 会议须知 （以下 简称"《股东大会议事规则》"）等相关规定，特制定本须知，请全体出席股东大 会的人员自觉遵守。 一、为确认出席大会的股东或其代理人或其他出席者的出席资格，会议工作 人员将对出席会议者的身份进行必要的核对工作，请被核对者给予配合。 二、经公司审核后符合参加本次股东大会条件的股东（含股东代理人）、董 事、监事、高级管理人员及其他出席人员方可出席本次会议；公司有权拒 ...

Group 1: Financial Performance and Taxation - The company will continue to recognize stock incentive expenses in 2025, specifically for 21,100 restricted shares allocated to 5 incentive recipients from the 2021 plan [1] - The income tax expense for Q4 2024 reached CNY 15 million, primarily due to the reduction in deductible amounts related to stock payment expenses after the lifting of restrictions on restricted shares [1] - The increase in sales expenses by CNY 10 million in Q1 is attributed to online promotion costs, which are considered non-recurring [2] Group 2: Business Development and Strategy - The 2025 business development plan includes increased investment in R&D and production resources for baked goods and frozen prepared dishes, aiming to meet customer demands for rapid innovation [2] - The company plans to explore C-end business opportunities, leveraging its R&D advantages to develop differentiated products and diversify sales channels, including e-commerce and traditional retail [2] - Efforts will be made to enhance operational efficiency across all business segments, focusing on cost control in procurement, production, and logistics [2] - Brand building and customer service quality will be prioritized to ensure sustainable and high-quality growth [2] Group 3: Production and Capacity Management - The company operates through self-production, commissioned processing, and outsourcing, with most core products being self-produced [3] - In 2024, 20,000 tons of products were processed through commissioned processing, primarily for items like sesame balls and spring rolls, which are produced using standard equipment and processes [3] - Future decisions on converting commissioned processing to self-production will depend on market conditions and operational assessments [3] Group 4: Financing Plans - The company plans to raise CNY 300 million through a simplified procedure for issuing shares to specific investors, pending approval from the 2024 annual shareholders' meeting [4] - The specific use of the funds for acquisitions or expansion of production has not yet been determined, and further disclosures will be made as developments occur [4]

格尔软件股份有限公司 2024 年年度股东大会会议资料 格尔软件股份有限公司 二零二四年年度股东大会 会议资料 格尔软件股份有限公司 2024 年年度股东大会会议资料 股东大会会议须知 为了维护全体股东的合法权益，确保股东大会的正常秩序和议事效率，保证大会的顺利 进行，根据《中华人民共和国公司法》《中华人民共和国证券法》、中国证监会发布的《上 市公司股东大会规则》及《格尔软件股份有限公司章程》（以下简称"《公司章程》"）和 《股东大会议事规则》的规定，特制定本须知，望出席股东大会的全体人员遵照执行。 一、格尔软件股份有限公司（以下简称"公司"或"本公司"）根据《中华人民共和国 公司法》《中华人民共和国证券法》及《公司章程》的规定，认真做好召开股东大会的各项 工作。 二、本公司设立股东大会秘书处，具体负责大会有关程序方面的事宜。 三、本次股东大会以现场会议形式召开，并采取现场、网络相结合的方式投票。 四、股东参加股东大会现场会议依法享有发言权、质询权、表决权等权利，同时也必须 认真履行法定义务，不得侵犯其他股东的权益和扰乱会议秩序。 五、股东要求大会发言，请于会前十五分钟向大会秘书处登记，出示持股的有效证明， ...

Core Viewpoint - The company has approved a share repurchase plan aimed at enhancing investor confidence and supporting employee incentive programs, with a total repurchase amount estimated between RMB 33 million and RMB 66 million [1][3][9]. Summary by Sections Share Repurchase Plan - The board of directors has approved a share repurchase plan without requiring shareholder meeting approval, allowing for the repurchase of between 1.5 million and 3 million shares, representing approximately 0.8042% to 1.6085% of the company's total share capital [1][3]. - The maximum repurchase price is set at RMB 22.00 per share, leading to a total estimated repurchase fund of approximately RMB 66 million if the upper limit is reached [1][9]. Purpose and Use of Repurchased Shares - The repurchased shares will be used for employee stock ownership plans and equity incentives, aiming to align the interests of shareholders, the company, and employees [3][9]. - If the repurchased shares are not fully allocated within three years after the disclosure of the repurchase results, the unallocated shares will be canceled [3][9]. Funding and Financial Position - The funding for the repurchase will come from the company's own funds and self-raised funds, with a commitment from China Industrial Bank to provide a loan of up to RMB 50 million [6][13]. - As of December 31, 2024, the company reported total assets of RMB 2.227 billion and a debt ratio of 56.02%, indicating a stable financial position [8][9]. Implementation Timeline and Conditions - The repurchase will be conducted within 12 months from the board's approval date, with specific conditions under which the repurchase may be terminated or adjusted [1][6]. - The company will disclose the progress of the repurchase regularly, including any significant changes in the number of shares repurchased [14]. Risk Factors - The plan may face risks such as the stock price exceeding the repurchase price cap, which could hinder the implementation of the repurchase [2][15]. - There are also risks related to potential changes in the company's operational or financial conditions that could affect the execution of the repurchase plan [2][15].

Core Points - The company has completed the registration of stock options under the 2024 stock option and restricted stock incentive plan, with a total of 785,700 stock options reserved for 90 individuals [1][2] - The stock options have a maximum validity period of 60 months, with a waiting period of 12 and 24 months for different tranches [2] - The estimated total expense for the stock options is approximately 14.86 million yuan, with annual amortization affecting net profit over the years 2025 to 2027 [3][4] Group 1: Stock Option Details - The stock option grant date is set for March 28, 2025, with the number of options adjusted from 827,700 to 785,700 due to three individuals voluntarily forfeiting their options [1] - The first exercise period allows for 50% of the options to be exercised after 12 months, while the second exercise period allows for the remaining 50% after 24 months [2] Group 2: Financial Impact - The company will recognize the cost of the stock options in its financial statements, with the fair value calculated using the Black-Scholes model [3] - The estimated accounting cost will impact net profit, but the incentive plan is expected to enhance employee motivation and operational efficiency, positively influencing company performance [4]

证券代码：301326 证券简称：捷邦科技 公告编号：2025-039 捷邦精密科技股份有限公司 （http://www.cninfo.com.cn）等指定信息披露媒体披露了相关文件。相关议案已 经第二届董事会薪酬与考核委员会第一次会议审议通过。公司监事会对本激励计 划的相关事项进行核实并发表了核查意见。 （二）2024 年 3 月 29 日至 2024 年 4 月 9 日，公司将本激励计划首次授予 激励对象的姓名和职务在公司内部予以公示。截至公示期满，公司监事会未收到 任何对本激励计划首次授予激励对象提出的异议。2024 年 4 月 10 日，公司披露 了《捷邦精密科技股份有限公司监事会关于 2024 年限制性股票与股票期权激励 计划首次授予激励对象名单的核查意见》。 （三）2024 年 4 月 15 日，公司召开 2024 年第一次临时股东大会，审议通 过了《关于公司<2024 年限制性股票与股票期权激励计划（草案）>及其摘要的 议案》《关于公司<2024 年限制性股票与股票期权激励计划考核管理办法>的议 案》《关于提请股东大会授权董事会办理公司 2024 年限制性股票与股票期权激 励计划相关事宜的议案》 ...

4. 这次股权激励没有高管吗？ 答: 您好！公司2025年限制性股票激励计划的实施旨在稳定现有核 心人员和吸引外籍高端人才的加入，公司希望通过本激励计划将更加促 进公司核心人才队伍的建设和稳定，从而有助于公司的长远发展。 证券代码：300461 证券简称：田中精机 浙江田中精机股份有限公司 投资者关系活动记录表 编号：2025-01 | 投资者关系活动类 | ☐特定对象调研 ☐分析师会议 | | --- | --- | | 别 | | | | ☐媒体采访 业绩说明会 | | | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 参与单位名称及 | 线上参与公司2024年度网上业绩说明会的全体投资者 | | 人员姓名 | | | 时间 | 2025年5月9日 15:30-16:30 | | 地点 | 价值在线（https://www.ir-online.cn/）网络互动 | | | 董事长、总经理 肖永富先生 | | 上市公司接待人员 | 独立董事 胡世华先生 | | 姓名 | 财务总监 刘广涛先生 | | | 董事会秘书 俞文斌先生 | | | 1. 2 ...